Recruitment is closed for this study
The main purpose of this study is to determine how consuming pasteurised milk containing the A2 beta casein variant may improve the normal function of the gastrointestinal tract and reduce inflammatory biomarkers in healthy volunteers with mild symptoms of regular milk intolerance.
We aim to recruit healthy people, male or female, who occasionally drink milk and experience symptoms of mild to moderate gastrointestinal discomfort in the few hours following milk intake. These symptoms may include increased gases, bloating and abdominal pain and must not be associated with any known lactose intolerance or milk protein allergy. You need to be between 18 and 56 years of age, non-smoking and free from disease. Females taking the contraceptive pill or hormone replacement therapy (HRT) can take part. Females who are pregnant, lactating or planning to be pregnant will not be able to take part in the study. At the beginning of your study participation, you will receive a health check and we will fully assess your eligibility to take part in the study.